1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Beckman Coulter, Inc. - Strategy and SWOT Report

Beckman Coulter, Inc. - Strategy and SWOT Report

  • December 2015
  • -
  • MarketLine
  • -
  • 23 pages

Introduction

Beckman Coulter, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Features:

- Detailed information on Beckman Coulter, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Beckman Coulter, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Beckman Coulter, Inc. including a breakdown and examination of key business segments

- Intelligence on Beckman Coulter, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Beckman Coulter, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Beckman Coulter (or 'the company') is an indirect, wholly-owned subsidiary of Danaher Corporation (Danaher). The company is engaged in the design, manufacture and marketing of biomedical testing instrument systems, tests and supplies in the US, Canada, Latin America, Europe, Asia Pacific, the Middle East and Africa. The company is headquartered in Brea, California. Beckman Coulter is a subsidiary of Danaher, and has not disclosed its financial data, including total revenues, and operating and net profits.

Reasons to Purchase:

- Gain understanding of Beckman Coulter, Inc. and the factors that influence its strategies

- Track strategic initiatives of the company and latest corporate news and actions

- Assess Beckman Coulter, Inc. as a prospective partner, vendor or supplier

- Support sales activities by understanding your customers' businesses better

- Stay up to date on Beckman Coulter, Inc.’s business structure, strategy and prospects

Table Of Contents

Beckman Coulter, Inc. - Strategy and SWOT Report
Company Overview
Business Description
History
Key Employees and Biographies
Company View
Locations and Subsidiaries
SWOT Analysis
Revenue Analysis
Key Competitors
Major Products and Services

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Coagulation Factor XI (Plasma Thromboplastin Antecedent ...

Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Review, H2 2016

Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Tissue ...

Ceres Nanosciences, Inc. - Product Pipeline Analysis, 2016 Update

Ceres Nanosciences, Inc. - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • October 2016
  • by Global Data

Summary Ceres Nanosciences, Inc. (Ceres Nanosciences) is a biotechnology company that offers development of nanotechnology for laboratory research and diagnostics platforms. The company conducts research, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.